Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
Iasis Molecular Sciences, Inc. logo — Leading the way in minimizing healthcare-acquired infections...

Iasis Molecular Sciences, Inc.

Leading the way in minimizing healthcare-acquired infections and improving wound healing with innovative, cost-effective solutions for all patients.

Founded 2008 United States Spokane, United States 3 employees Grant Total: $1.25M Biotechnology

General Information

Company Name Iasis Molecular Sciences, Inc.
Founded Year 2008
Location United States Spokane, United States
Employees 3
Industries Biotechnology
Funding Stage Grant
Social

BounceWatch is an independent company data service, not affiliated with Iasis Molecular Sciences, Inc.. To contact Iasis Molecular Sciences, Inc., visit iasismolecular.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Iasis Molecular Sciences, Inc. compare?

A PDF of Iasis Molecular Sciences, Inc. and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Iasis Molecular Sciences, Inc. soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Iasis Molecular Sciences, Inc.

Iasis Molecular Sciences, Inc. is a biotechnology startup that is leading the way in minimizing healthcare-acquired infections and improving wound healing with innovative and cost-effective solutions for all patients. The company, founded in 2008 and based in the United States, has developed and patented a suite of technologies focused on reducing infections related to implantable medical devices, surgical wounds, and treating infections and tissue loss from chronic wounds and burns. Iasis Molecular Sciences & Novion Technologies have garnered attention due to their proprietary antimicrobial agent technologies, which are designed to be straightforward and cost-effective, making them accessible to patients of various backgrounds. The startup's last investment, a $1.25M grant investment, was received on 25 January 2022 from the Congressionally Directed Medical Research Programs. Promising results from preclinical testing have sparked optimism about the company's potential to provide valuable, life-enhancing solutions for patients needing implantable medical device therapies, those suffering from topical infections and inflammation, and individuals experiencing secondary tissue loss due to burns, periodontal disease, and abnormal healing, such as chronic wounds. Iasis Molecular Sciences, Inc. is well-positioned to make significant strides in the biotechnology industry with its innovative solutions for improving patient outcomes and reducing healthcare-acquired infections.

Business keywords: Healthcare-Associated Infections, Antimicrobial Solutions, Wound Care, Antimicrobial Materials, Advanced Dressings, Infection Control, Antiseptics, Biocides, Chronic Wounds, Burn Trauma, Periodontal Disease, Implantable Medical Devices, Preclinical Testing, Tissue Loss

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Grant $1.25M 1
Congressionally Directed Medical Research Programs
Congressionally Directed Medical Research Programs
25 Jan 2022
Seed Round Undisclosed 1
Mountain Man Ventures
01 Aug 2016

Iasis Molecular Sciences, Inc. Alternatives & Competitors

View All Alternatives
Iasis Molecular Sciences, Inc. vs
Imbed Biosciences Inc.
Imbed Biosciences Inc. United States

Advanced Materials for Soft Tissue Repair and Regeneration

Convertible Note
38 employees
Biotechnology, Health Care
Iasis Molecular Sciences, Inc. vs
Nobio
Nobio Israel

MAKING THINGS ANTIMICROBIAL, FOR LIFE.

Grant
26 employees
Biotechnology, Medical Devices
Iasis Molecular Sciences, Inc. vs
Omini
Omini France

Multiplex blood testing platform to monitor chronic diseases like heart failure Project co-funded by...

58 employees
Biotechnology, Health Care
View all alternatives

FAQ About Iasis Molecular Sciences, Inc.

Leading the way in minimizing healthcare-acquired infections and improving wound healing with innovative, cost-effective solutions for all patients.
Iasis Molecular Sciences, Inc. was founded in 2008.
Iasis Molecular Sciences, Inc. is headquartered in Spokane, United States.
Iasis Molecular Sciences, Inc. operates in Biotechnology. Its work centres on Healthcare-Associated Infections, Antimicrobial Solutions, Wound Care and Antimicrobial Materials.
Iasis Molecular Sciences, Inc. has approximately 3 employees.
Iasis Molecular Sciences, Inc. has completed 2 funding rounds, raising a total of $1.25M. The latest funding stage is Grant.
Top alternatives and competitors to Iasis Molecular Sciences, Inc. include Imbed Biosciences Inc., Nobio, Omini. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Iasis Molecular Sciences, Inc. and Imbed Biosciences Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Iasis Molecular Sciences, Inc., https://bouncewatch.com/company/iasis-molecular-sciences-inc, updated 4 January 2025. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout